Verastem (VSTM) Operating Income (2011 - 2026)

Verastem (VSTM) recorded quarterly Operating Income of -$44.9 million in Q1 2026, down 153.03% quarter-over-quarter from $84.7 million in Q4 2025, and down 1.64% on a YoY basis from -$45.6 million in Q1 2025.

Verastem (VSTM) Operating Income (2011 - 2026) Analysis & Trends

Verastem's Operating Income history runs 16 years deep, the most recent figure standing at -$44.9 million for Q1 2026.

  • In Q1 2026, Operating Income fell 1.64% year-over-year to -$44.9 million; the TTM figure through Mar 2026 stood at -$44.7 million (up 65.89% YoY), while the FY2025 annual figure was -$44.0 million, up 61.73% from the prior year.
  • Operating Income was -$44.9 million for Q1 2026 at Verastem, down from $84.7 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $84.7 million in Q4 2025 to a low of -$44.9 million in Q1 2026.
  • Historically, Operating Income has averaged -$21.7 million across 5 years, with a median of -$21.4 million in 2022.
  • Biggest YoY gain for Operating Income was 368.01% in 2025; the steepest drop was 139.45% in 2025.
  • A 5-year view of Operating Income shows it stood at -$16.8 million in 2022, then tumbled by 84.85% to -$31.1 million in 2023, then decreased by 1.45% to -$31.6 million in 2024, then soared by 368.01% to $84.7 million in 2025, then plunged by 153.03% to -$44.9 million in 2026.
  • The last three Operating Income figures came in at -$44.9 million (Q1 2026), $84.7 million (Q4 2025), and -$40.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -32.68 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -19.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -15.76 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.14 Bn
9 Abivax 91.96 Bn 91.96 Bn - -65.83 Mn
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn -44.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -44.90 Mn
Dec 31, 2025 84.67 Mn
Sep 30, 2025 -40.72 Mn
Jun 30, 2025 -43.76 Mn
Mar 31, 2025 -44.17 Mn
Dec 31, 2024 -31.59 Mn
Sep 30, 2024 -37.03 Mn
Jun 30, 2024 -18.28 Mn
Mar 31, 2024 -28.06 Mn
Dec 31, 2023 -31.14 Mn
Sep 30, 2023 -21.31 Mn
Jun 30, 2023 -20.29 Mn
Mar 31, 2023 -19.34 Mn
Dec 31, 2022 -16.85 Mn
Sep 30, 2022 -17.71 Mn
Jun 30, 2022 -21.40 Mn
Mar 31, 2022 -16.98 Mn
Dec 31, 2021 -16.51 Mn
Sep 30, 2021 -14.85 Mn
Jun 30, 2021 -15.94 Mn